UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Jul 15, 2026
Sale
Calculated transaction value
$440.28K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Jul 14, 2026
Public filing date
Jul 15, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$526.66
Jul 14, 2026
Close before public filing
$526.66
Jul 14, 2026
Return since public filing
-2.13%
Through Aug 28, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 840 shares @ $524.15
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000098
Filing cohort
Transactions in this filing
Showing 11 of 11
Trades
11
Issuers
1
Estimated value
$6.29M
Buys / sales
0 / 9
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Jul 14, 2026 | $1.29M |
| United Therapeutics Corp UTHR Current | Sale | Jul 14, 2026 | $440.28K |
| United Therapeutics Corp UTHR | Sale | Jul 14, 2026 | $770.94K |
| United Therapeutics Corp UTHR | Sale | Jul 14, 2026 | $1.84M |
| United Therapeutics Corp UTHR | Sale | Jul 14, 2026 | $643.01K |
| United Therapeutics Corp UTHR | Sale | Jul 14, 2026 | $348.57K |
| United Therapeutics Corp UTHR | Sale | Jul 14, 2026 | $507.51K |
| United Therapeutics Corp UTHR | Sale | Jul 14, 2026 | $293.99K |
| United Therapeutics Corp UTHR | Sale | Jul 14, 2026 | $56.83K |
| United Therapeutics Corp UTHR | Sale | Jul 14, 2026 | $106.52K |
| United Therapeutics Corp UTHR | Exercise | Jul 14, 2026 | $0 |